Dosage & Administration Efficacy safety testing Drug label Prior authorization Financial assistance

Herceptin hylecta

(hyaluronidase / trastuzumab)

5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection [Herceptin Hylecta]

Dosage & administration

For subcutaneous use only. HERCEPTIN HYLECTA has different dosage and administration instructions than intravenous trastuzumab products.

Do not administer intravenously.

Do not substitute HERCEPTIN HYLECTA for or with ado-trastuzumab emtansine.

Perform HER2 testing using FDA-approved tests by laboratories with demonstrated proficiency.

The recommended dose of HERCEPTIN HYLECTA is 600 mg/10,000 units (600 mg trastuzumab and 10,000 units hyaluronidase) administered subcutaneously over approximately 2-5 minutes once every three weeks.

eficacy, safety & testing

Herceptin hylecta clinical details

Clinical Trial, Efficacy & Safety

drug label

Herceptin hylecta prescribing information

Have more Herceptin hylecta questions?

Submit MSL Request

Learn More

Need to report a Herceptin hylecta issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Herceptin hylecta Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

Coverage Authorization Appeals

Patient Consent Form

Patient Consent Form - Spanish

Learn More

Benefits investigation

Herceptin Hylecta Prescriber Service & Patient Consent Form

Herceptin Hylecta Prescriber Service Form - Online Portal

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Herceptin hylecta Financial assistance options

Co-pay savings program

commercial only

Herceptin Hylecta Prescriber Service & Patient Consent Form

Herceptin Hylecta Prescriber Service Form - Online Portal

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Herceptin Hylecta Prescriber Service & Patient Consent Form

Herceptin Hylecta Prescriber Service Form - Online Portal

Genentech Patient Foundation Application Form (1/2)

Genentech Patient Foundation Application Form (2/2) - Patient Consent Form

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Herceptin hylecta Patient education

Getting started on Herceptin hylecta

NOT PROVIDED BY BRANDInstructions For Use: HER2+ Breast Cancer

Patient toolkit

NOT PROVIDED BY BRANDNot Provided By Brand

Learn More

Herceptin hylecta FAQs

FAQ Data Source

Can't find what you're looking for?

Our trained staff can help you:

Please note:

Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.

Herceptin hylecta

Dosage & administration

eficacy, safety & testing

Herceptin hylecta clinical details

drug label

Herceptin hylecta prescribing information

Have more Herceptin hylecta questions?

Need to report a Herceptin hylecta issue?

prior authorization

Herceptin hylecta Prior authorization resources

Benefits investigation

Reimbursement help (FRM)

financial assistance

Herceptin hylecta Financial assistance options

Co-pay savings program

Bridge program

Foundation programs

patient education

Herceptin hylecta Patient education

Getting started on Herceptin hylecta

Patient toolkit

people also ask

Herceptin hylecta FAQs

Can't find what you're looking for?